| Bioactivity | Prulifloxacin (NM441) is an orally active fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and -negative bacteria. Prulifloxacin is a prodrug of a thiazeto-quinoline carboxylic acid derivative Ulifloxacin (NM394). Prulifloxacin has the potential for lower urinary tract infections and exacerbations of chronic bronchitis[1][2]. | ||||||||||||
| Name | Prulifloxacin | ||||||||||||
| CAS | 123447-62-1 | ||||||||||||
| Formula | C21H20FN3O6S | ||||||||||||
| Molar Mass | 461.46 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Prulifloxacin
CAS: 123447-62-1 F: C21H20FN3O6S W: 461.46
Prulifloxacin (NM441) is an orally active fluoroquinolone antibiotic with a broad spectrum of activity against Gram-posi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.